Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group.

Article Details

Citation

Rinat C, Wanders RJ, Drukker A, Halle D, Frishberg Y

Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group.

J Am Soc Nephrol. 1999 Nov;10(11):2352-8.

PubMed ID
10541294 [ View in PubMed
]
Abstract

Primary hyperoxaluria type 1 is an autosomal recessive inherited metabolic disease in which excessive oxalates are formed by the liver and excreted by the kidneys, causing a wide spectrum of phenotypes ranging from renal failure in infancy to mere renal stones in late adulthood. Mutations in the AGXT gene, encoding the liver-specific enzyme alanine:glyoxylate aminotransferase, are responsible for the disease. Seven mutations were detected in eight families in Israel. Four of these mutations are novel and three occur in children living in single-clan villages. The mutations are scattered along various exons (1, 4, 5, 7, 9, 10), and on different alleles comprising at least five different haplotypes. All but one of the mutations are in a homozygous pattern, reflecting the high rate of consanguinity in our patient population. Two affected brothers are homozygous for two different mutations expressed on the same allele. The patients comprise a distinct ethnic group (Israeli Arabs) residing in a confined geographic area. These results, which are supported by previous data, suggest for the first time that the phenomenon of multiple mutations in a relatively closed isolate is common and almost exclusive to the Israeli-Arab population. Potential mechanisms including selective advantage to heterozygotes, digenic inheritance, and the recent emergence of multiple mutations are discussed.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Serine--pyruvate aminotransferaseP21549Details